A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
Public ClinicalTrials.gov record NCT00211185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Phase II Study to Determine the Safety and Efficacy of the Combination of ONTAK With CHOP in Peripheral T-Cell Lymphoma.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study of ONTAK and CHOP (chemotherapy drugs) to find out their ability to make Peripheral T-cell lymphoma disappear (for any period of time) and potentially lengthen life. The study will also compare what kind of side effects these drugs cause and how often they occur. The hypothesis is that patients with newly diagnosed peripheral T-Cell lymphoma, when given ONTAK + CHOP, will tolerate the treatment and will have a 20% improvement in response rate when compared to CHOP alone.
Study identification
- NCT ID
- NCT00211185
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- Denileukin diftitox Drug
- Cyclophosphamide Drug
- Doxorubicin Drug
- Vincristine Drug
- Prednisone Drug
- Pegfilgrastim Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2004 (Actual)
- Primary completion
- Aug 2008 (Actual)
- Completion
- Dec 23, 2009 (Actual)
- Last update posted
- Mar 18, 2020
2004 – 2009
United States locations
- U.S. sites
- 49
- U.S. states
- 22
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Hematology and Oncology | Birmingham | Alabama | 35205 | — |
| Hematology Oncology Associates | Phoenix | Arizona | 85012 | — |
| Stanford Cancer Center | Stanford | California | 94305-5826 | — |
| Rocky Mountain Cancer Center | Denver | Colorado | 80218 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06250 | — |
| Ocala Oncology Center | Ocala | Florida | 34474 | — |
| Cancer Centers of Florida, P.A. | Ocoee | Florida | 34761 | — |
| Hematology Oncology Associates of IL | Chicago | Illinois | 60611 | — |
| Robert H. Lurie Comprehensive Cancer Center | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Cancer Care & Hematology Specialists of Chicagoland | Niles | Illinois | 60714 | — |
| Siouxland Hematology Oncology | Sioux City | Iowa | 51101 | — |
| Kansas City Cancer Centers | Lenexa | Kansas | 66214 | — |
| Dana Farber/ Harvard Cancer Center | Boston | Massachusetts | 02115 | — |
| New England Medical Center | Boston | Massachusetts | — | — |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| Kansas City Cancer Centers | Kansas City | Missouri | 64111 | — |
| St. Joseph Oncology Inc. | Saint Joseph | Missouri | 64507 | — |
| Arch Medical Services | St Louis | Missouri | 63141 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Hematology Oncology Associates of NNJ | Morristown | New Jersey | 07960 | — |
| New Mexico Cancer Care Associates | Santa Fe | New Mexico | 87505 | — |
| New York Oncology Hematology, P.C. | Albany | New York | 12208 | — |
| Raleigh Hematology Oncology Associates | Cary | North Carolina | 27511 | — |
| Barrett Cancer Center-University of Cincinnati | Cincinnati | Ohio | 45206 | — |
| Greater Dayton Cancer Center | Kettering | Ohio | 45409 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111-2497 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29605 | — |
| Texas Cancer Center | Arlington | Texas | 76014 | — |
| Marnie McFaddin Ward Cancer Center | Beaumont | Texas | 77702-1449 | — |
| Texas Oncology,P.A. | Bedford | Texas | 76022 | — |
| Texas Cancer Center at Medical City | Dallas | Texas | 75230-2510 | — |
| The Texas Cancer Center | Dallas | Texas | 75237 | — |
| El Paso Cancer Treatment Center | El Paso | Texas | 79915 | — |
| Texas Oncology | Fort Worth | Texas | 76104 | — |
| Texas Oncology | Garland | Texas | 75042-5788 | — |
| Longview Cancer Center | Longview | Texas | 75601 | — |
| Allison Cancer Center | Midland | Texas | 79701-5946 | — |
| West Texas Cancer Center | Odessa | Texas | 79761 | — |
| HOAST Medical Dr. | San Antonio | Texas | 78229 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Waco Cancer Care and Research Center | Waco | Texas | 76712 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Oncology and Hematology Associates of SW VA Inc. | Salem | Virginia | 24153 | — |
| Puget Sound Cancer Center | Edmonds | Washington | 98026 | — |
| Cancer Care Northwest | Spokane | Washington | 99218 | — |
| Northwest Cancer Specialists | Vancouver | Washington | 98684 | — |
| Yakima Valley Memorial Hospital/North Star Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00211185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2020 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00211185 live on ClinicalTrials.gov.